|
| Profile | Definition | Description |
|
| 1 | Critical cardiogenic shock
(crash and burn) | Patients with life-threatening hypotension despite rapidly escalating inotropic support, critical organ hypoperfusion, often confirmed by worsening acidosis. |
|
| 2 | Progressive decline
(sliding on inotropes) | Patient with declining function despite intravenous inotropic support may be manifest by worsening renal function, nutritional depletion, and inability to restore volume balance. Also it describes declining status in patients unable to tolerate inotropic therapy. |
|
| 3 | Stable but inotrope dependent
(dependent stability) | Patient with stable blood pressure, organ function, nutrition, and symptoms on continuous intravenous inotropic support (or a temporary circulatory support device or both), but demonstrating repeated failure to wean from support due to recurrent symptomatic hypotension or renal dysfunction. |
|
| 4 | Resting symptoms | Patient can be stabilized close to normal volume status but experiences daily symptoms of congestion at rest or during ADL. Doses of diuretics generally fluctuate at very high levels. More intensive management and surveillance strategies should be considered, which may in some cases reveal poor compliance that would compromise outcomes with any therapy. Some patients may shuttle between 4 and 5. |
|
| 5 | Exertion intolerant | Comfortable at rest and with ADL but unable to engage in any other activity, living predominantly within the house. Patients are comfortable at rest without congestive symptoms but may have underlying refractory elevated volume status, often with renal dysfunction. If underlying nutritional status and organ function are marginal, patient may be more at risk than INTERMACS 4 and require definitive intervention. |
|
| 6 | Exertion limited
(walking wounded) | Patient without evidence of fluid overload is comfortable at rest and with activities of daily living and minor activities outside the home but fatigue after the first few minutes of any meaningful activity. Attribution to cardiac limitation requires careful measurement of peak oxygen consumption, in some cases with hemodynamic monitoring to confirm severity of cardiac impairment. |
|
| 7 | Advanced NYHA III | A placeholder for more precise specification in future; this level includes patients who are without current or recent episodes of unstable fluid balance, living comfortably with meaningful activity limited to mild physical exertion. |
|
